BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$73.99 USD
-0.53 (-0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $73.99 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for BioTechne Corp falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 1,159 | 1,137 | 1,106 | 931 | 739 |
Cost Of Goods | 389 | 367 | 349 | 298 | 256 |
Gross Profit | 770 | 770 | 757 | 633 | 483 |
Selling & Adminstrative & Depr. & Amort Expenses | 563 | 471 | 460 | 396 | 326 |
Income After Depreciation & Amortization | 207 | 299 | 297 | 237 | 157 |
Non-Operating Income | -5 | 51 | 16 | -75 | 138 |
Interest Expense | 16 | 11 | 11 | 14 | 19 |
Pretax Income | 186 | 339 | 301 | 148 | 276 |
Income Taxes | 18 | 53 | 38 | 9 | 47 |
Minority Interest | 0 | 0 | -9 | -1 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 168 | 285 | 263 | 140 | 229 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 168 | 285 | 272 | 140 | 229 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 318 | 406 | 398 | 325 | 240 |
Depreciation & Amortization (Cash Flow) | 112 | 107 | 101 | 88 | 83 |
Income After Depreciation & Amortization | 207 | 299 | 297 | 237 | 157 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 160.77 | 161.86 | 164.12 | 161.93 | 157.60 |
Diluted EPS Before Non-Recurring Items | 1.57 | 1.79 | 1.75 | 1.43 | 0.97 |
Diluted Net EPS (GAAP) | 1.05 | 1.76 | 1.66 | 0.87 | 1.46 |
Fiscal Year end for BioTechne Corp falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 306.10 | 303.43 | 272.60 | 276.94 | 301.32 |
Cost Of Goods | 102.75 | 98.83 | 96.01 | 91.74 | 96.62 |
Gross Profit | 203.35 | 204.60 | 176.59 | 185.19 | 204.70 |
SG&A, R&D, and Dept/Amort Expenses | 157.53 | 137.60 | 138.59 | 129.33 | 110.17 |
Income After SG&A, R&D, and Dept/Amort Expenses | 45.82 | 67.00 | 38.00 | 55.86 | 94.53 |
Non-Operating Income | 8.25 | -5.91 | -4.62 | -6.30 | 1.60 |
Interest Expense | 15.74 | 0.00 | 0.00 | 0.00 | 11.22 |
Pretax Income | 41.66 | 61.08 | 33.39 | 49.56 | 88.32 |
Income Taxes | 1.07 | 12.03 | 5.92 | -1.44 | 12.83 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 40.59 | 49.06 | 27.47 | 50.99 | 75.48 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 40.59 | 49.06 | 27.47 | 50.99 | 75.48 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 160.65 | 160.50 | 160.06 | 161.94 | 161.92 |
Diluted EPS Before Non-Recurring Items | 0.49 | 0.44 | 0.33 | 0.35 | 0.56 |
Diluted Net EPS (GAAP) | 0.26 | 0.31 | 0.17 | 0.31 | 0.47 |